Table 2.
Main studies examining antineoplastic mechanisms of Hericium erinaceus against colorectal cancer
Ref.
|
H. erinaceus fraction employed
|
Colonic cancer model
|
Identified mechanism
|
Kim et al[119], 2011 | Hot water/ microwave ethanol extraction extracts | CT-26 cancer cells graft in mice | NK cells activity ↑; macrophages activity ↑; angiogenesis ↓ |
Li et al[77], 2014 | Polysaccharides | HT-29 cancer cells graft in mice | - |
Lee et al[65], 2017 | Erinacine A | Cancer cells (HCT-116, DLD1) | PI3K/AKT/mTOR/; p70S6K pathway; ROS ↑ |
Sharif et al[120], 2018 | Ethanolic and methanolic extracts | Cancer cells (HT-29) | α-glucosidase activity ↑; anti-tyrosinase activity ↓ |
Liu et al[116], 2020 | Polysaccharides | Cancer cells (HCT-116) | CDK1 ↓; CDK2 ↓; Cyclin A2 ↓; MCM5 ↓ |
Hou et al[118], 2020 | Polysaccharides | Cancer cells (HCT-116, DLD1) | Clived caspases 3,9 ↑; ROS ↑; Bax ↑; Bcl-2 ↓ |
NK: Natural killer; PI3K: Phosphatidylinositol 3-Kinase; AKT: Protein kinase B; mTOR: Mechanistic target of rapamycin; p70S6K: Ribosomal protein S6 kinase beta-1; CDK: Cyclin-dependent kinase; MCM5: Mini-chromosomal maintenance protein 5; ROS: Reactive oxygen species; Bax: Bcl-2-like protein 4; Bcl-2: B-cell lymphoma 2.